“The Management of Brain Metastases”
Patchell, R. a. The management of brain metastases. Cancer Treat. Rev. 29, 533–540.
“Distribution of Brain Metastases”
Delattre JY1, Krol G, Thaler HT, Posner JB. Arch Neurol. 1988 Jul;45(7):741-4.
“The Value of 4-Month Neurocognitive Function as an Endpoint in Brain Metastases Trials”
Onodera S1, Aoyama H, Tha KK, Hashimoto N, Toyomaki A, Terae S, Shirato H. J Neurooncol. 2014 Nov;120(2):311-9. doi: 10.1007/s11060-014-1550-y. Epub 2014 Jul 19.
“A New Treatment Paradigm: Neoadjuvant Radiosurgery Before Surgical Resection of Brain Metastases with Analysis of Local Tumor Recurrence”
Asher AL1, Burri SH2, Wiggins WF3, Kelly RP4, Boltes MO5, Mehrlich M5, Norton HJ6, Fraser RW2.
“The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline”
J Neurooncol. 2010 Jan; 96(1): 71–83.
“The biology of brain metastases-translation to new therapies”
Eichler, A. F., Nat. Rev. Clin. Oncol. 8, 344–56 (2011).
“A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy”
Metz JM1, Smith D, Mick R, Lustig R, Mitchell J, Cherakuri M, Glatstein E, Hahn SM. Clin Cancer Res. 2004 Oct 1;10(19):6411-7
“Future directions in treatment of brain metastases”
Barani IJ1, Larson DA, Berger MS.Surg Neurol Int. 2013 May 2;4(Suppl 4):S220-30. doi: 10.4103/2152-7806.111299. Print 2013.
“The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited”
Fidler IJ. Nat Rev Cancer. 2003 Jun;3(6):453-8. doi: 10.1038/nrc1098.
“The pathogenesis of cancer metastasis”
Poste G, Fidler IJ. Nature. 1980 Jan 10;283(5743):139-46.
“The pathogenesis and treatment of brain metastases: a comprehensive review”
Tosoni A1, Ermani M, Brandes AA.Crit Rev Oncol Hematol. 2004 Dec;52(3):199-215.
“Brain Metastases: Epidemiology and Pathophysiology”
Joohee Sul, Jerome B. Posner
“Navigation in surgery”
Langenbecks Arch Surg. 2013 Apr; 398(4):501–514.
“Clinical application of RapidArc volumetric modulated arc therapy as a component in whole brain radiation therapy for poor prognostic, four or more multiple brain”
Radiation Oncol J. 2012 Jun; 30(2): 5–61. Published online 2012 Jun 30. doi: 10.3857/roj.2012.30.2.53
